Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

EBS News and Commentary

Caps

How do you think EBS will perform against the market?

Add Stock to CAPS Watchlist

All Players

487 Outperform
17 Underperform
 

All-Star Players

80 Outperform
3 Underperform
 

Wall Street

7 Outperform
1 Underperform
 

Top EBS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

sprucemoose2 (< 20)
Submitted January 05, 2009

has a constant revenue stream from the good ole US of A and sticks to its 50 day MA very well

gopyerk (88.14)
Submitted March 08, 2013

Projecting earnings declines for 3 of 4 quarters coming up. I think in the long term there are some things to like here, but for the short run, when considering the negative growth picture I just don't like this

EBS VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about EBS.

Recs

0
Member Avatar Paco57 (33.20) Submitted: 3/27/2018 10:46:57 PM : Outperform Start Price: $53.13 EBS Score: +0.50

Staggering.

Recs

0
Member Avatar samphrone (< 20) Submitted: 2/17/2015 8:27:11 PM : Outperform Start Price: $28.90 EBS Score: +61.71

rock solid.

Recs

0
Member Avatar NathanHamilton82 (< 20) Submitted: 3/25/2014 5:01:38 PM : Outperform Start Price: $25.51 EBS Score: +71.53

Emergent BioSolutions has a mononpoly on anthrax vaccines supplied to the government under multi-year sole source contracts. The company is capacity constrained, and with the US governments $100m investment in expanding capacity, Emergent is on track to triple production through 2017. 100%+ upside!

Leaderboard

Find the members with the highest scoring picks in EBS.

Score Leader

Sandman333

Sandman333 (27.19) Score: +970.02

I picked this stock on the principle that it had sound financials, was picked outperform by many CAPS All-Stars, and had recently tanked for no apparent reason.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Sandman333 27.19 11/15/2007 Outperform 5Y $4.70 +1,061.28% +91.26% +970.02 0 Comment
stewartsjunk 70.60 12/18/2007 Outperform 5Y $4.81 +1,034.72% +91.16% +943.56 0 Comment
DBerriman < 20 11/27/2007 Outperform 3W $4.79 +1,039.46% +96.40% +943.06 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. CantSitStill 32.37 11/29/2007 Outperform 3Y $4.99 +993.79% +89.76% +904.03 0 Comment
jessba15 54.39 11/28/2007 Outperform 1Y $5.00 +991.60% +93.69% +897.91 0 Comment
orsibros 69.77 11/28/2007 Outperform 5Y $5.00 +991.60% +93.69% +897.91 0 Comment
TRIPODTODD 61.47 12/4/2007 Outperform 3W $5.17 +955.71% +90.26% +865.44 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. caslonsvcs 95.48 12/27/2007 11/20/2017 Outperform 3M $5.25 +939.62% +87.20% +852.42 0 Comment
tenmiles 32.37 11/14/2007 Outperform 3Y $5.71 +855.87% +87.90% +767.96 3 Comments
no12call 41.42 1/7/2008 Outperform 3M $6.60 +726.97% +95.79% +631.18 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPiperJaff 87.01 6/11/2012 Outperform NS $14.33 +280.88% +98.68% +182.20 0 Comment
TrackUltraLong < 20 3/14/2012 Outperform NS $15.83 +244.72% +90.37% +154.36 1 Comment
trackwbbsecuriti < 20 7/14/2010 Outperform NS $17.14 +218.44% +143.87% +74.57 0 Comment
TrackWedbush 88.44 3/20/2009 Outperform NS $12.44 +338.75% +246.96% +91.79 0 Comment
TrackCarisandCo 91.86 3/6/2009 Outperform NS $17.76 +207.32% +290.91% -83.59 0 Comment
TrackJimCramer 85.01 12/1/2008 Underperform 3W $22.37 +143.99% +233.09% +89.10 0 Comment
TrackCarisandCo 91.86 10/14/2008 Outperform NS $13.89 +74.30% -23.27% +97.56 2/17/2009 @ $24.21 0 Comment
TrackHSBC 36.26 1/3/2007 Outperform NS $11.40 +378.77% +98.90% +279.87 0 Comment
TrackCowenandCo 83.56 1/3/2007 Outperform NS $11.40 +378.77% +98.90% +279.87 0 Comment

Featured Broker Partners


<